Cargando…
A Drug Safety Concept (I) to Avoid Polypharmacy Risks in Transplantation by Individual Pharmacotherapy Management in Therapeutic Drug Monitoring of Immunosuppressants
For several, also vital medications, such as immunosuppressants in solid organ and hematopoietic stem cell transplantation, therapeutic drug monitoring (TDM) remains the only strategy for fine-tuning the dosage to the individual patient. Especially in severe clinical complications, the intraindividu...
Autor principal: | Wolf, Ursula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535417/ https://www.ncbi.nlm.nih.gov/pubmed/37765269 http://dx.doi.org/10.3390/pharmaceutics15092300 |
Ejemplares similares
-
Individual Pharmacotherapy Management (IPM)—IV: Optimized Usage of Approved Antimicrobials Addressing Under-Recognized Adverse Drug Reactions and Drug-Drug Interactions in Polypharmacy
por: Wolf, Ursula, et al.
Publicado: (2022) -
A Review on Therapeutic Drug Monitoring of Immunosuppressant Drugs
por: Mohammadpour, Niloufar, et al.
Publicado: (2011) -
Underdiagnosed CKD in Geriatric Trauma Patients and Potent Prevention of Renal Impairment from Polypharmacy Risks through Individual Pharmacotherapy Management (IPM-III)
por: Wolf, Ursula, et al.
Publicado: (2023) -
Optimising pharmacotherapy in older cancer patients with polypharmacy
por: Vrijkorte, Elze, et al.
Publicado: (2019) -
Identification and evaluation of cases of polypharmacy and irrational pharmacotherapy in Georgia
por: Gabunia, L, et al.
Publicado: (2023)